Veradigm (NASDAQ:MDRX) Trading Up 11% – Should You Buy?

Shares of Veradigm Inc. (NASDAQ:MDRX) rose 11% on Friday . The stock traded as high as $9.99 and last traded at $9.99. Approximately 89,232 shares changed hands during trading, a decline of 95% from the average daily volume of 1,671,841 shares. The stock had previously closed at $9.00.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on Veradigm in a research report on Thursday. They issued a “hold” rating on the stock. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $12.00.

Veradigm Stock Up 2.8 %

The company has a 50 day moving average of $9.54 and a two-hundred day moving average of $9.11.

Institutional Trading of Veradigm

A number of institutional investors and hedge funds have recently made changes to their positions in MDRX. Innealta Capital LLC acquired a new stake in Veradigm in the 2nd quarter valued at $38,000. Meadow Creek Wealth Advisors LLC purchased a new position in Veradigm during the first quarter valued at $83,000. Tyro Capital Management LLC acquired a new stake in shares of Veradigm in the first quarter valued at about $9,055,000. Finally, Vanguard Group Inc. increased its stake in shares of Veradigm by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after purchasing an additional 95,291 shares in the last quarter.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.